Document Detail

Acupuncture for postchemotherapy fatigue: a phase II study.
MedLine Citation:
PMID:  15117996     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To determine whether improvement in postchemotherapy fatigue following acupuncture treatment is substantial enough to warrant a controlled trial. PATIENTS AND METHODS: We accrued patients at Memorial Sloan-Kettering Cancer Center who had completed cytotoxic chemotherapy but experienced persisting fatigue. Patients with severe anemia, clinical depression, or Karnofsky performance status score less than 70 were excluded. Thirty-seven patients were registered in two cohorts; 31 provided follow-up data. Patients received acupuncture either twice per week for 4 weeks (25 patients) or once per week for 6 weeks (12 patients). The primary end point was change in score on the Brief Fatigue Inventory between baseline and 2 weeks after the final treatment. A baseline Brief Fatigue Inventory score of four or greater was an eligibility requirement for the trial. RESULTS: Patients had completed cytotoxic chemotherapy an average of more than 2 years previously. Baseline fatigue scores were high, with approximately half of the sample scoring in the "severe" range. Mean improvement following acupuncture was 31.1% (95% CI, 20.6% to 41.5%), meeting our prespecified criterion for declaring acupuncture worthy of further study. Increasing age was associated with poorer response and failure to complete the study. There was no important difference in improvement following once-weekly and twice-weekly treatments. CONCLUSION: Acupuncture is worthy of further study in the treatment of postchemotherapy fatigue.
Andrew J Vickers; David J Straus; Bertha Fearon; Barrie R Cassileth
Related Documents :
3305036 - Piroxicam in acute musculoskeletal disorders and sport injuries.
20729966 - Long-term follow up of diclofenac sodium 3% in 2.5% hyaluronic acid gel for actinic ker...
6510016 - Comparison of slow-release indomethacin and diflunisal in patients with arthrosis.
24071046 - Is local bone graft sufficient to maintain the surgical correction in adolescent idiopa...
18602566 - Results of total knee replacement for isolated patellofemoral arthritis: when not to pe...
23895276 - Safe temperature range for intraoperative and early postoperative continuous hypertherm...
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical oncology : official journal of the American Society of Clinical Oncology     Volume:  22     ISSN:  0732-183X     ISO Abbreviation:  J. Clin. Oncol.     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-04-30     Completed Date:  2004-05-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8309333     Medline TA:  J Clin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1731-5     Citation Subset:  IM    
Intergrative Medicine Service, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acupuncture Therapy*
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / adverse effects*,  therapeutic use
Fatigue / etiology*,  therapy*
Middle Aged
Neoplasms / drug therapy*
Severity of Illness Index
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cancer patient preferences for communication of prognosis in the metastatic setting.
Next Document:  Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspect...